Nerai Bio is advancing the frontier of genome editing with a new generation of ultra-precise CRISPR enzymes engineered to unlock genomic targets beyond the reach of existing technologies. Our proprietary MORPHEME platform combines AI and high-throughput protein engineering via directed evolution to design bespoke genome editors with unmatched specificity and therapeutic potential. Our mission is to create a world where no genetic disease is too rare, too hard, or too complex to cure. At Nerai, we don’t just edit DNA—we aim to rewrite the future of patients.

Nerai Bioscience

Org chart

Teams

Offices